Main content area

Aptamer-based nanostructured interfaces for the detection and release of circulating tumor cells

Ding, Pi, Wang, Zhili, Wu, Zeen, Zhu, Weipei, Liu, Lifen, Sun, Na, Pei, Renjun
Journal of materials chemistry B 2020 v.8 no.16 pp. 3408-3422
blood, immunogenicity, monitoring, neoplasm cells, neoplasms, oligonucleotides, patients, prognosis, therapeutics
Analysis of circulating tumor cells (CTCs) can provide significant clinical information for tumors, which has proven to be helpful for cancer diagnosis, prognosis monitoring, treatment efficacy, and personalized therapy. However, CTCs are an extremely rare cell population, which challenges the isolation of CTCs from patient blood. Over the last few decades, many strategies for CTC detection have been developed based on the physical and biological properties of CTCs. Among them, nanostructured interfaces have been widely applied as CTC detection platforms to overcome the current limitations associated with CTC capture. Furthermore, aptamers have attracted significant attention in the detection of CTCs due to their advantages, including good affinity, low cost, easy modification, excellent stability, and low immunogenicity. In addition, effective and nondestructive release of CTCs can be achieved by aptamer-mediated methods that are used under mild conditions. Herein, we review some progress in the detection and release of CTCs through aptamer-functionalized nanostructured interfaces.